Keynote address: Cellular reduction of nitroimidazole drugs: Potential for selective chemotherapy and diagnosis of hypoxic cells

This publication has 32 references indexed in Scilit:

• Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)
  British Journal of Cancer, 1986
• Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivo
  British Journal of Cancer, 1984
• SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
  International Journal of Radiation Oncology*Biology*Physics, 1981
• The application in radiation therapy of substances which modify cellular radiation response
  Cancer, 1977
• Radiobiological characterization of the inactivating events produced in mammalian cells by helium and heavy ions
  International Journal of Radiation Oncology*Biology*Physics, 1977
• Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to X rays
  The British Journal of Radiology, 1973
• Radiosensitization of Mammalian Cells byp-Nitroacetophenone
  International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1972
• Radiosensitization of Mammalian Cells byp-nitroacetophenone
  International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1971
• Electron Affinic Sensitization
  International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1971